Cargando…

A Genetically Defined Male Counterpart of Polycystic Ovary Syndrome: Evidence for Ovarian-Independent Pathogenesis

Background: Polycystic ovary syndrome (PCOS) is a heterogeneous condition that affects 6-10% of women of reproductive age. PCOS is often characterized by a triad of ovulatory dysfunction, hyperandrogenism, and cardiometabolic dysfunction. Both ovarian-related and ovarian-independent factors have bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Jia, Wittemans, Laura Brigitte Leen, Lindgren, Cecilia, Hirschhorn, Joel N, Chan, Yee-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089555/ http://dx.doi.org/10.1210/jendso/bvab048.1574

Ejemplares similares

Evidence From Men for Ovary-independent Effects of Genetic Risk Factors for Polycystic Ovary Syndrome
por: Zhu, Jia, et al.
Publicado: (2021)

SUN-012 Role of Leptin-Receptor Expressing Cells in the Pathogenesis of Polycystic Ovary Syndrome (PCOS)
por: Cara, Alexandra, et al.
Publicado: (2020)

MON-215 Comparison of Ultrasonographic and Biochemical Markers of Polycystic Ovarian Morphology Across the Phenotypic Spectrum of Polycystic Ovary Syndrome
por: Jarrett, Brittany, et al.
Publicado: (2019)

SAT353 Relevance of Ovarian Morphology Among Adolescents With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

OR35-03 Uncovering Causative Mutations in Polycystic Ovary Syndrome
por: Srivastava, Jaya, et al.
Publicado: (2023)

FRI409 Childbirth Experiences In Women With Polycystic Ovary Syndrome
por: Husby, Anne Engtrø, et al.
Publicado: (2023)

MON-205 Is Muscle Mechanical Function Altered In Polycystic Ovary Syndrome?
por: Caliskan Guzelce, Ezgi, et al.
Publicado: (2019)

SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
por: Parveen, Sanober, et al.
Publicado: (2019)

SUN-018 No Difference in Breastfeeding Rates in Women with Polycystic Ovary Syndrome
por: Bui, Leeann, et al.
Publicado: (2020)

FRI457 Protein-coding Genetic Variation In Polycystic Ovary Syndrome
por: Parker, Chloe, et al.
Publicado: (2023)

OR35-06 Polycystic Ovary Syndrome Is Associated With an Increased Mortality Risk
por: Ollila, Meri-Maija, et al.
Publicado: (2023)

Polycystic Ovary Syndrome as Metabolic Disease: New Insights on Insulin Resistance
por: Genazzani, Alessandro D, et al.
Publicado: (2023)

MON-233 Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome
por: Legro, Richard, et al.
Publicado: (2019)

SAT-024 Investigating Racial and Ethnic Comorbidity Patterns of Polycystic Ovary Syndrome
por: Actkins, Ky’Era, et al.
Publicado: (2020)

Genetic Sex Effects of Polycystic Ovary Syndrome Reveal Distinct Metabolic Etiology
por: Actkins, Ky’Era, et al.
Publicado: (2021)

OR15-5 Cognitive Function in Reproductive Aged Individuals with Polycystic Ovary Syndrome
por: Cedars, Marcelle, et al.
Publicado: (2022)

SAT370 Economic Burden of Endometrial Cancer Associated with Polycystic Ovary Syndrome
por: Pace, Lauren Arielle, et al.
Publicado: (2023)

MON-213 Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Factors in Reproductive-Age Women with Polycystic Ovary Syndrome (PCOS) Using the 2014 Androgen Excess and PCOS Society Criteria for the Polycystic Ovarian Morphology
por: Kazemi, Maryam, et al.
Publicado: (2019)

MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome
por: Hoyos, Luis, et al.
Publicado: (2019)

MON-207 Identification of Monogenic Causes of Polycystic Ovary Syndrome by High Throughput Sequencing
por: Crespo, Raiane, et al.
Publicado: (2019)

SAT-017 Relationship Between Vitamin D Levels and Signs of Polycystic Ovary Syndrome
por: Smykalova, Anastasia, et al.
Publicado: (2020)

MON-037 Vitamin D Levels in Women with Polycystic Ovary Syndrome: Influence of Obesity
por: Maidana, Patricia Nieves Amelia, et al.
Publicado: (2020)

Overnight Melatonin Concentration and Sleep Quality Are Associated With Clinical Features of Polycystic Ovary Syndrome
por: Evans, Adam T, et al.
Publicado: (2021)

Lifestyle and Weight Change in Women With Polycystic Ovary Syndrome During COVID19 Pandemic
por: Eyupoglu, Nesrin Damla, et al.
Publicado: (2021)

SAT381 Effect of Obesity on Androgen-induced Splenic Dysregulation in Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2023)

FRI399 Prevalence Of Polycystic Ovary Syndrome In Women With Type 1 Diabetes In Pregnancy
por: Dolatabadi, Samin, et al.
Publicado: (2023)

OR20-01 Machine Learning-based Steroid Metabolome Analysis In Women With Polycystic Ovary Syndrome Reveals Three Distinct Androgen Excess Subtypes With Different Metabolic Risk Profiles.
por: Rocha, Thaís P, et al.
Publicado: (2023)

OR31-01 A Randomized Controlled Trial of a Lifestyle Intervention with Longitudinal Follow up on Ovarian Dysmorphology, Hyperandrogenism, and Menstrual Irregularity in Women with Polycystic Ovary Syndrome
por: Kazemi, Maryam, et al.
Publicado: (2020)

SUN-025 Obesity Severity and Polycystic Ovary Syndrome in an Ethnically Diverse Cohort of Adolescent Girls
por: Khil, Jaclyn, et al.
Publicado: (2020)

Abnormalities in Microarchitecture and Reduced Mechanical Bone Strength in a Rat Model of Polycystic Ovary Syndrome
por: Comim, Fabio Vasconcellos, et al.
Publicado: (2021)

Hepatic Dysregulation of Bile Acid Homeostasis in Hyperandrogenemic Female Mouse Model of Polycystic Ovary Syndrome
por: Huffman, Alexandra M, et al.
Publicado: (2021)

THU636 Prevalence Of Metabolic Syndrome In A Sample Of Hispanic Patients With Polycystic Ovary Syndrome
por: Arroyo, Isabel C, et al.
Publicado: (2023)

SAT388 Does Obesity Drive the Development of Polycystic Ovary Syndrome (PCOS)? An Epidemiologic Study
por: Amiri, Mina, et al.
Publicado: (2023)

SAT-018 Androgen Actions in Adipose Tissue and the Brain Are Key Mediators in the Development of Polycystic Ovary Syndrome
por: Cox, Madeleine J, et al.
Publicado: (2020)

SUN-020 Waist Circumference Is Associated with Insulin Resistance in Young Korean Women with Polycystic Ovary Syndrome
por: Song, Do Kyeong, et al.
Publicado: (2020)

SAT-015 Incidence and Predictors of Hypertension in a Cohort of Australian Women with and Without Polycystic Ovary Syndrome
por: Kakoly, Nadira Sultana, et al.
Publicado: (2020)

SUN-019 Androgens Modulate Lipid Metabolism and Absorption in Control and Polycystic Ovary-Metabolic Syndrome Conditions
por: Vine, Donna Faye, et al.
Publicado: (2020)

PMON208 METFORMIN, SPIRONOLACTONE AND ORAL CONTRACEPTIVES IN POLYCYSTIC OVARY SYNDROME: A NETWORK META-ANALYSIS
por: Rodriguez-Gutierrez, Rene, et al.
Publicado: (2022)

PMON243 Metabolic Disorders Genetically Modify Polycystic Ovary Syndrome through its Candidate Hormones
por: Actkins, Ky’Era, et al.
Publicado: (2022)

LBMON234 Ultrasonographic Criteria In The Diagnosis Of Polycystic Ovary Syndrome: A Systematic Review And Meta Analysis
por: Pea, Jeffrey, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u62d1ai3fv83nh335otmut73jk